
Immix Biopharma Investor Relations Material
Latest events

Status Update
Immix Biopharma

Q2 2025
8 Aug, 2025

Corporate Presentation
30 Jun, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Immix Biopharma Inc
Access all reports
Immix Biopharma Inc is a U.S.-based clinical-stage biopharmaceutical company focused on developing therapies for cancer and inflammatory diseases. The company’s lead programs are based on its proprietary tissue-specific therapeutics platform, designed to deliver biologics and small molecules to specific tissues while minimizing systemic toxicity. Immix Biopharma conducts clinical trials for rare and hard-to-treat cancers, as well as immune-related conditions. The company is headquartered in Los Angeles, California, and its shares are listed on the NASDAQ.
Key slides for Immix Biopharma Inc


Investor Presentation
Immix Biopharma Inc


Corporate Presentation
Immix Biopharma Inc
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
IMMX
Country
🇺🇸 United States